Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 10 | 2025 | 115 | 4.180 |
Why?
|
| Air Pollution | 10 | 2024 | 75 | 3.030 |
Why?
|
| Environmental Exposure | 10 | 2024 | 245 | 2.840 |
Why?
|
| Maternal Exposure | 11 | 2025 | 156 | 2.780 |
Why?
|
| Particulate Matter | 12 | 2025 | 80 | 2.590 |
Why?
|
| Fluorocarbons | 7 | 2018 | 60 | 2.310 |
Why?
|
| DDT | 3 | 2020 | 6 | 1.600 |
Why?
|
| Birth Weight | 6 | 2025 | 356 | 1.560 |
Why?
|
| Insecticides | 3 | 2020 | 62 | 1.520 |
Why?
|
| Environmental Pollutants | 5 | 2018 | 81 | 1.480 |
Why?
|
| Pregnancy | 32 | 2025 | 7600 | 1.400 |
Why?
|
| Occupational Exposure | 6 | 2022 | 139 | 1.290 |
Why?
|
| Premature Birth | 4 | 2020 | 419 | 1.270 |
Why?
|
| Oil and Gas Industry | 3 | 2018 | 5 | 1.160 |
Why?
|
| Air Pollution, Indoor | 3 | 2018 | 34 | 1.110 |
Why?
|
| Alkanesulfonic Acids | 5 | 2018 | 12 | 1.040 |
Why?
|
| Natural Gas | 3 | 2022 | 5 | 0.940 |
Why?
|
| Nitrogen Dioxide | 5 | 2022 | 18 | 0.930 |
Why?
|
| Metals, Heavy | 3 | 2021 | 23 | 0.870 |
Why?
|
| Texas | 20 | 2025 | 3719 | 0.860 |
Why?
|
| Environmental Monitoring | 6 | 2023 | 91 | 0.800 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2024 | 243 | 0.790 |
Why?
|
| Caprylates | 2 | 2012 | 13 | 0.760 |
Why?
|
| Oil and Gas Fields | 2 | 2019 | 9 | 0.760 |
Why?
|
| Norway | 9 | 2018 | 29 | 0.740 |
Why?
|
| Ozone | 2 | 2019 | 20 | 0.740 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 3 | 2020 | 14 | 0.730 |
Why?
|
| Female | 48 | 2025 | 72054 | 0.720 |
Why?
|
| Parity | 3 | 2016 | 89 | 0.710 |
Why?
|
| Cooking | 2 | 2018 | 38 | 0.700 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 238 | 0.690 |
Why?
|
| Hydraulic Fracking | 1 | 2020 | 1 | 0.680 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2016 | 43 | 0.680 |
Why?
|
| Pregnancy Outcome | 3 | 2020 | 637 | 0.680 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2019 | 37 | 0.620 |
Why?
|
| Adult | 30 | 2025 | 31962 | 0.620 |
Why?
|
| Fertility | 2 | 2012 | 270 | 0.610 |
Why?
|
| Residence Characteristics | 3 | 2020 | 293 | 0.570 |
Why?
|
| Swine | 5 | 2024 | 1213 | 0.570 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 41 | 0.560 |
Why?
|
| Bayes Theorem | 3 | 2024 | 315 | 0.560 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 494 | 0.540 |
Why?
|
| Arsenic | 2 | 2020 | 49 | 0.540 |
Why?
|
| South Africa | 4 | 2020 | 127 | 0.530 |
Why?
|
| Humans | 54 | 2025 | 134225 | 0.530 |
Why?
|
| Time-to-Pregnancy | 1 | 2016 | 2 | 0.520 |
Why?
|
| Zygote | 1 | 2016 | 31 | 0.520 |
Why?
|
| Maternal Age | 1 | 2016 | 141 | 0.490 |
Why?
|
| Gene Targeting | 1 | 2016 | 185 | 0.490 |
Why?
|
| Inflammation | 3 | 2022 | 1595 | 0.450 |
Why?
|
| Embryonic Development | 1 | 2016 | 225 | 0.450 |
Why?
|
| Reproductive Health | 1 | 2015 | 49 | 0.450 |
Why?
|
| Pesticides | 2 | 2022 | 31 | 0.450 |
Why?
|
| Sulfonamides | 1 | 2016 | 289 | 0.440 |
Why?
|
| Mental Disorders | 1 | 2022 | 890 | 0.440 |
Why?
|
| Young Adult | 11 | 2019 | 9963 | 0.440 |
Why?
|
| Stillbirth | 3 | 2019 | 103 | 0.440 |
Why?
|
| Benzene | 3 | 2020 | 24 | 0.430 |
Why?
|
| Occupational Diseases | 2 | 2014 | 75 | 0.420 |
Why?
|
| Swine Diseases | 2 | 2024 | 42 | 0.410 |
Why?
|
| Asthma | 2 | 2019 | 812 | 0.410 |
Why?
|
| Noise, Occupational | 3 | 2019 | 3 | 0.400 |
Why?
|
| Fetal Development | 3 | 2022 | 135 | 0.390 |
Why?
|
| Fetal Macrosomia | 1 | 2012 | 20 | 0.380 |
Why?
|
| Life Style | 1 | 2015 | 464 | 0.370 |
Why?
|
| Rural Population | 3 | 2021 | 281 | 0.370 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 54 | 0.360 |
Why?
|
| Volatile Organic Compounds | 2 | 2022 | 13 | 0.350 |
Why?
|
| Cohort Studies | 9 | 2022 | 5225 | 0.340 |
Why?
|
| Agrochemicals | 1 | 2010 | 13 | 0.330 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 80 | 0.330 |
Why?
|
| Infant, Newborn | 8 | 2025 | 8640 | 0.320 |
Why?
|
| Agriculture | 2 | 2007 | 34 | 0.320 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 938 | 0.320 |
Why?
|
| Odds Ratio | 5 | 2016 | 1338 | 0.320 |
Why?
|
| Disasters | 2 | 2021 | 106 | 0.310 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2010 | 63 | 0.310 |
Why?
|
| CRISPR-Cas Systems | 2 | 2024 | 298 | 0.290 |
Why?
|
| Logistic Models | 5 | 2017 | 1909 | 0.290 |
Why?
|
| Gestational Age | 3 | 2022 | 1230 | 0.280 |
Why?
|
| Tinnitus | 2 | 2019 | 23 | 0.270 |
Why?
|
| Biomarkers | 6 | 2020 | 3434 | 0.270 |
Why?
|
| Heart Transplantation | 2 | 2024 | 889 | 0.270 |
Why?
|
| Prevalence | 5 | 2021 | 2685 | 0.270 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 148 | 0.260 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 393 | 0.250 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2006 | 15 | 0.250 |
Why?
|
| Pilot Projects | 5 | 2022 | 1493 | 0.250 |
Why?
|
| Transients and Migrants | 1 | 2006 | 24 | 0.250 |
Why?
|
| Occupational Health | 1 | 2006 | 48 | 0.240 |
Why?
|
| Hearing Loss | 2 | 2019 | 214 | 0.230 |
Why?
|
| Gene Editing | 2 | 2024 | 213 | 0.230 |
Why?
|
| Self Report | 2 | 2020 | 553 | 0.230 |
Why?
|
| Housing | 2 | 2016 | 54 | 0.230 |
Why?
|
| Papio | 1 | 2024 | 60 | 0.220 |
Why?
|
| CD40 Ligand | 1 | 2024 | 65 | 0.220 |
Why?
|
| Case-Control Studies | 5 | 2019 | 3678 | 0.220 |
Why?
|
| Mothers | 2 | 2013 | 372 | 0.220 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 63 | 0.220 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2024 | 123 | 0.210 |
Why?
|
| Exercise | 2 | 2020 | 875 | 0.210 |
Why?
|
| Serine Endopeptidases | 1 | 2024 | 201 | 0.210 |
Why?
|
| Industry | 2 | 2021 | 29 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2016 | 94 | 0.210 |
Why?
|
| Solvents | 2 | 2022 | 46 | 0.200 |
Why?
|
| Military Personnel | 2 | 2016 | 204 | 0.200 |
Why?
|
| Urban Population | 3 | 2021 | 244 | 0.200 |
Why?
|
| Water Wells | 1 | 2022 | 1 | 0.190 |
Why?
|
| Health Status Disparities | 1 | 2025 | 252 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 874 | 0.190 |
Why?
|
| Fetal Weight | 1 | 2022 | 72 | 0.190 |
Why?
|
| Picornaviridae | 1 | 2022 | 21 | 0.190 |
Why?
|
| Graft Survival | 1 | 2024 | 482 | 0.190 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.190 |
Why?
|
| Picornaviridae Infections | 1 | 2022 | 53 | 0.180 |
Why?
|
| Data Collection | 1 | 2023 | 399 | 0.180 |
Why?
|
| Child, Preschool | 4 | 2024 | 14897 | 0.180 |
Why?
|
| Seasons | 1 | 2023 | 333 | 0.180 |
Why?
|
| Cognition | 2 | 2024 | 819 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 820 | 0.180 |
Why?
|
| Deer | 1 | 2021 | 15 | 0.180 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2022 | 78 | 0.180 |
Why?
|
| Canada | 1 | 2022 | 346 | 0.180 |
Why?
|
| Virus Replication | 1 | 2024 | 636 | 0.170 |
Why?
|
| British Columbia | 1 | 2020 | 11 | 0.170 |
Why?
|
| Disaster Planning | 1 | 2021 | 64 | 0.170 |
Why?
|
| Animals, Genetically Modified | 2 | 2024 | 344 | 0.170 |
Why?
|
| Child | 7 | 2024 | 25917 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1419 | 0.170 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2020 | 170 | 0.160 |
Why?
|
| Fires | 1 | 2020 | 12 | 0.160 |
Why?
|
| Informal Sector | 1 | 2019 | 1 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17591 | 0.160 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 16 | 0.160 |
Why?
|
| Lipids | 2 | 2013 | 565 | 0.160 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 1008 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 920 | 0.150 |
Why?
|
| Smoking | 2 | 2016 | 1136 | 0.150 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2016 | 6 | 0.150 |
Why?
|
| Temperature | 1 | 2019 | 327 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 115 | 0.150 |
Why?
|
| Biomass | 1 | 2018 | 23 | 0.150 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2018 | 51 | 0.140 |
Why?
|
| Menstrual Cycle | 1 | 2018 | 37 | 0.140 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 34 | 0.140 |
Why?
|
| Particle Size | 1 | 2018 | 148 | 0.140 |
Why?
|
| Water Quality | 1 | 2017 | 10 | 0.140 |
Why?
|
| Linear Models | 2 | 2017 | 723 | 0.140 |
Why?
|
| Water Microbiology | 1 | 2017 | 31 | 0.140 |
Why?
|
| Groundwater | 1 | 2017 | 9 | 0.140 |
Why?
|
| Menstruation | 1 | 2017 | 31 | 0.140 |
Why?
|
| Geography, Medical | 1 | 2017 | 18 | 0.140 |
Why?
|
| Animals | 8 | 2024 | 36526 | 0.130 |
Why?
|
| Sex Ratio | 1 | 2016 | 13 | 0.130 |
Why?
|
| Mental Health | 1 | 2020 | 374 | 0.130 |
Why?
|
| Mexican Americans | 1 | 2018 | 206 | 0.130 |
Why?
|
| Heating | 1 | 2016 | 1 | 0.130 |
Why?
|
| Blastocyst | 1 | 2016 | 79 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 4008 | 0.130 |
Why?
|
| Aged | 3 | 2020 | 21822 | 0.130 |
Why?
|
| United States | 7 | 2019 | 11798 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 33 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2022 | 6617 | 0.120 |
Why?
|
| Risk Factors | 7 | 2019 | 11196 | 0.120 |
Why?
|
| Marijuana Abuse | 1 | 2016 | 54 | 0.120 |
Why?
|
| Gravidity | 1 | 2015 | 12 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 245 | 0.120 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 367 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2017 | 507 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 3759 | 0.110 |
Why?
|
| Pesticide Residues | 1 | 2014 | 5 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2017 | 827 | 0.110 |
Why?
|
| Cost of Illness | 1 | 2016 | 277 | 0.110 |
Why?
|
| Adolescent | 5 | 2018 | 20647 | 0.110 |
Why?
|
| Mosquito Control | 1 | 2014 | 36 | 0.110 |
Why?
|
| Middle Aged | 6 | 2019 | 29430 | 0.100 |
Why?
|
| Bacteria | 1 | 2017 | 537 | 0.100 |
Why?
|
| Malaria | 1 | 2014 | 105 | 0.100 |
Why?
|
| Infant | 3 | 2024 | 13263 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2018 | 604 | 0.100 |
Why?
|
| Seafood | 1 | 2012 | 10 | 0.100 |
Why?
|
| Body Burden | 1 | 2012 | 3 | 0.100 |
Why?
|
| Food Contamination | 1 | 2012 | 29 | 0.100 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 85 | 0.090 |
Why?
|
| Diet Surveys | 1 | 2012 | 103 | 0.090 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2012 | 60 | 0.090 |
Why?
|
| Male | 9 | 2021 | 66215 | 0.090 |
Why?
|
| Neoplasms | 1 | 2007 | 3036 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2012 | 251 | 0.090 |
Why?
|
| Hazardous Substances | 1 | 2011 | 18 | 0.090 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2011 | 20 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2011 | 91 | 0.090 |
Why?
|
| Progestins | 1 | 2011 | 53 | 0.090 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 63 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2011 | 51 | 0.090 |
Why?
|
| Contraceptive Agents, Female | 1 | 2011 | 31 | 0.090 |
Why?
|
| Confidence Intervals | 2 | 2011 | 300 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 454 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2016 | 1722 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 239 | 0.080 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 123 | 0.080 |
Why?
|
| Age Factors | 1 | 2016 | 2997 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 471 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1409 | 0.080 |
Why?
|
| United States Environmental Protection Agency | 1 | 2008 | 8 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 365 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 295 | 0.070 |
Why?
|
| Social Class | 1 | 2008 | 210 | 0.070 |
Why?
|
| Rural Health | 1 | 2007 | 52 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1721 | 0.060 |
Why?
|
| United States Department of Defense | 2 | 2016 | 10 | 0.060 |
Why?
|
| Diet | 1 | 2013 | 1195 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2021 | 3754 | 0.060 |
Why?
|
| Spouses | 1 | 2006 | 71 | 0.060 |
Why?
|
| Virus Shedding | 1 | 2024 | 82 | 0.060 |
Why?
|
| Gene Knockout Techniques | 1 | 2024 | 139 | 0.050 |
Why?
|
| Heart Valves | 1 | 2024 | 54 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 216 | 0.050 |
Why?
|
| Heterografts | 1 | 2024 | 201 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2024 | 276 | 0.050 |
Why?
|
| Influenza A virus | 1 | 2024 | 152 | 0.050 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2024 | 189 | 0.050 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2022 | 17 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 485 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2771 | 0.050 |
Why?
|
| Anodontia | 1 | 2022 | 33 | 0.050 |
Why?
|
| Receptors, Peptide | 1 | 2022 | 54 | 0.050 |
Why?
|
| Alopecia | 1 | 2022 | 41 | 0.050 |
Why?
|
| Soil | 1 | 2021 | 72 | 0.040 |
Why?
|
| China | 1 | 2021 | 296 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 2171 | 0.040 |
Why?
|
| Incidence | 1 | 2008 | 3424 | 0.040 |
Why?
|
| Spain | 1 | 2020 | 65 | 0.040 |
Why?
|
| Conservation of Natural Resources | 1 | 2020 | 22 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2024 | 568 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2022 | 224 | 0.040 |
Why?
|
| Cadmium | 1 | 2020 | 31 | 0.040 |
Why?
|
| Soot | 1 | 2020 | 14 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2022 | 209 | 0.040 |
Why?
|
| Weather | 1 | 2019 | 14 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 176 | 0.040 |
Why?
|
| Environment | 1 | 2020 | 156 | 0.040 |
Why?
|
| Urban Health | 1 | 2019 | 79 | 0.040 |
Why?
|
| Toluene | 1 | 2019 | 11 | 0.040 |
Why?
|
| Benzene Derivatives | 1 | 2019 | 19 | 0.040 |
Why?
|
| Metals | 1 | 2019 | 65 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 262 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 332 | 0.040 |
Why?
|
| Hydrocarbons | 1 | 2017 | 9 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2017 | 60 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 313 | 0.030 |
Why?
|
| Risk | 1 | 2019 | 833 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2016 | 52 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 166 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 203 | 0.030 |
Why?
|
| Premenopause | 1 | 2015 | 42 | 0.030 |
Why?
|
| Women's Health | 1 | 2016 | 150 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 1588 | 0.030 |
Why?
|
| Breast | 1 | 2015 | 218 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 4802 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 855 | 0.030 |
Why?
|
| Phenotype | 1 | 2022 | 4611 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2014 | 409 | 0.020 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2011 | 16 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 1391 | 0.020 |
Why?
|
| Cholesterol | 1 | 2013 | 574 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2011 | 72 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 757 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5466 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 5085 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 13105 | 0.010 |
Why?
|